RLRoberto Leoncini

Roberto Leoncini

*This is an algorithmically generated author record based on publicly available information.

Current Organizations / Institutes

The organizations/institutes from the scholar's latest article

Previous Organizations / Institutes

The organizations / institutes from the scholar's other articles in the past ten years


Roberto Leoncini has a total of 272 co-authors. Here are the top co-authors by number of shared publications:


Latest Publications

  • Open Access

    Performance Evaluation of Automated Erythrocyte Sedimentation Rate (ESR) Analyzers in a Multicentric Study

    by Flaminia Tomassetti, Cinzia Calabrese, Fabio Bertani, Michele Cennamo, Daniela Diamanti, Alfredo Giovannelli, Roberto Guerranti, Roberto Leoncini, Maria Lorubbio, Agostino Ognibene, et al.

    Background: Erythrocyte Sedimentation Rate (ESR) is an easy test used to diagnose and monitor inflammatory and infectious diseases. The aim of this study was the evaluation of the performance of three ESR automated analyzers, VES-MATIC 5, CUBE 30 TOUCH, and MINI-CUBE, involving four Italian polyclinics in Rome, Siena, Como, and Arezzo, as well as inter-site variability assessment to detect possible device-dependent and operator-dependent influences. Methods: Accuracy analysis was carried out by analyzing the same samples with all three instruments and comparing them with the Westergren method. Precision was assessed with quality control material through intra-run and inter-run precision. Repeatability was estimated by reanalyzing fresh blood samples belonging to three ESR ranges (low, intermediate, and high) six times. Results: The results showed a strong correlation (Spearman coefficients R2) between the manual method and VES-MATIC 5 (0.978), CUBE 30 TOUCH (0.981), and MINI-CUBE (0.974). The accuracy of all clinics was excellent, with coefficients of variation (CVs) of less than 10% for all instruments. Repeatability confirmed an excellent level for all ESR ranges, with CVs below 10%. Conclusions: The study proved that all three automated instruments offer optimal performance for accuracy and precision and are suitable for both large and small facilities without influences of the laboratory environment.


  • Open Access

    The Appetite−Suppressant and GLP-1-Stimulating Effects of Whey Proteins in Obese Subjects are Associated with Increased Circulating Levels of Specific Amino Acids

    by Antonello E. Rigamonti, Roberto Leoncini, Alessandra De Col, Sofia Tamini, Sabrina Cicolini, Laura Abbruzzese, Silvano G. Cella, Alessandro Sartorio

    The satiating effect of whey proteins depends upon their unique amino acid composition because there is no difference when comparing whey proteins or a mix of amino acids mimicking the amino acid composition of whey proteins. The specific amino acids underlying the satiating effect of whey proteins have not been investigated to date. Aims and Methods. The aim of the present study was to evaluate the appetite-suppressant effect of an isocaloric drink containing whey proteins or maltodextrins on appetite (satiety/hunger measured by a visual analogue scale or VAS), anorexigenic gastrointestinal peptides (circulating levels of glucagon-like peptide 1 (GLP-1) and peptide tyrosine tyrosine (PYY)) and amino acids (circulating levels of single, total [TAA] and branched-chain amino acids [BCAA]) in a cohort of obese female subjects (n = 8; age: 18.4 ± 3.1 years; body mass index, BMI: 39.2 ± 4.6 kg/m2). Results. Each drink significantly increased satiety and decreased hunger, the effects being more evident with whey proteins than maltodextrins. Similarly, circulating levels of GLP-1, PYY and amino acids (TAA, BCAA and alanine, arginine, asparagine, citrulline, glutamine, hydroxyproline, isoleucine, histidine, leucine, lysine, methionine, ornithine, phenylalanine, proline, serine, threonine, tyrosine, and valine) were significantly higher with whey proteins than maltodextrins. In subjects administered whey proteins (but not maltodextrins), isoleucine, leucine, lysine, methionine, phenylalanine, proline, tyrosine, and valine were significantly correlated with hunger (negatively), satiety, and GLP-1 (positively). Conclusions. Eight specific amino acids (isoleucine, leucine, lysine, methionine, phenylalanine, proline, tyrosine, and valine) were implicated in the appetite-suppressant and GLP-1-stimulating effects of whey proteins, which may be mediated by their binding with nutrient-sensing receptors expressed by L cells within the gastrointestinal wall. The long-term satiating effect of whey proteins and the effectiveness of a supplementation with these amino acids (i.e., as a nutraceutical intervention) administered during body weight reduction programs need to be further investigated.


  • Open Access

    Whey Proteins Reduce Appetite, Stimulate Anorexigenic Gastrointestinal Peptides and Improve Glucometabolic Homeostasis in Young Obese Women

    by Antonello E. Rigamonti, Roberto Leoncini, Claudia Casnici, Ornella Marelli, Alessandra De Col, Sofia Tamini, Elisa Lucchetti, Sabrina Cicolini, Laura Abbruzzese, Silvano G. Cella, et al.

    Introduction: Proteins, particularly whey proteins, represent the most satiating macronutrient in animals and humans. A dietetic regimen based on proteins enriched preload before eating might be a strategy to counteract obesity. Aims and Methods: The aim of the present study was to evaluate the effects of an isocaloric drink containing whey proteins or maltodextrins (preload) on appetite (satiety/hunger measured by a visual analogue scale or VAS), glucometabolic control (blood glucose/insulin), and anorexigenic gastrointestinal peptides (pancreatic polypeptide or PP, glucagon-like peptide 1 or GLP-1 and peptide YY or PYY) in a cohort of obese young women (n = 9; age: 18.1 ± 3.0 years; body mass index, BMI: 38.8 ± 4.5 kg/m2). After two and a half hours, they were administered with a mixed meal at a fixed dose; satiety and hunger were measured by VAS. Results: Each drink significantly augmented satiety and reduced hunger, and the effects were more evident with whey proteins than maltodextrins. Similarly, there were significant increases in GLP-1 and PYY levels (but not PP) after the ingestion of each drink; these anorexigenic responses were higher with whey proteins than maltodextrins. While insulinemia identically increased after each drink, whey proteins induced a lower glycemic response than maltodextrins. No differences in satiety and hunger were found after the meal, which is presumably due to the late administration of the meal test, when the hypophagic effect of whey proteins was disappearing. Conclusions: While whey proteins actually reduce appetite, stimulate anorexigenic gastrointestinal peptides, and improve glucometabolic homeostasis in young obese women, further additional studies are mandatory to demonstrate their hypophagic effects in obese subjects, when administered as preload before eating.


  • Open Access

    Traumatic myiasis in farmed animals caused by Wohlfahrtia magnifica in southern Italy (Diptera: Sarcophagidae)

    by Teresa Bonacci, Giuseppe Curia, Roberto Leoncini, Daniel Whitmore

    Ten herds of sheep and goats (455 heads) were inspected for the presence of traumatic myiasis between May and September 2013 in the province of Cosenza, Calabria, southern Italy. Nine cases were discovered in sheep, goats and a sheepdog. Infested body sites included external genitalia, wounds (sheep and sheepdog) and hooves (goats). Larvae were removed from the infested body areas and reared to adult stage in the laboratory. Both the larvae and the adults were identified as belonging to the Mediterranean screwworm fly Wohlfahrtia magnifica (Schiner, 1862) (Diptera: Sarcophagidae), an obligatory parasite of humans and warm-blooded vertebrates. To our knowledge, these are the first cases of wohlfahrtiosis in sheep and goats to be reported from Calabria. The infested animals were living outdoors in spring and summer, and enclosed in sheds during the autumn and winter months. Observed effects of the myiases included severely impeded walking and tissue damage. Wohlfahrtiosis can cause significant economic loss to farmers. Data about the local distribution, seasonality and types of infestation caused by W. magnifica are useful to farmers and vets to improve control systems, in Calabria as elsewhere within the distributional range of the species


  • Proteomic Investigation of Dermal Fibroblasts Isolated from Affected and Unaffected Skin Samples from Patients with Limited Cutaneous Systemic Sclerosis: 2 Distinct Entities?

    by Claudio Corallo, Annalisa Santucci, Giulia Bernardini, Natale Figura, Roberto Leoncini, Giulia Riolo, Antonio Montella, Chiara Chirico, Ranuccio Nuti, Nicola Giordano

    Objective To identify using proteomic analysis the proteins of altered abundance in the affected and unaffected limited cutaneous systemic sclerosis (lcSSc) skin fibroblasts. Methods Excision biopsies (3 mm) were obtained from the affected and unaffected skin of 5 patients with lcSSc. Dermal fibroblasts were isolated enzymatically. Two-dimensional gel electrophoresis was used to separate and define proteins in affected and unaffected fibroblast lysates. Proteins of altered abundance were identified by mass spectrometry. Differences among skin samples were confirmed also by immunohistochemistry (IHC) and by quantitative real-time PCR (qRT-PCR) for type I collagen (Col-1) and vimentin (VIM). Results Proteomic analysis revealed different expressions of proteins involved in cytoskeleton organization (27%), extracellular matrix remodeling (11%), response to oxidative stress (22%), energy metabolism (19%), protein metabolism (5%), cellular homeostasis (5%), signal transduction (3%), and protein transcription, synthesis, and turnover (8%). IHC analysis showed that SSc-affected epidermis is thickened and the dermis is strongly reactive to Col-1 and VIM (typical markers of activated myofibroblasts) compared to SSc-unaffected skin, whose stainings are comparable to those of control healthy skin. Overexpression of Col-1 and VIM mRNA levels in affected lcSSc fibroblasts compared to unaffected lcSSc ones was confirmed by qRT-PCR. Conclusion Consistent with previous studies, these findings are important for 2 reasons: first, because they reveal the opposite behavior of dermal fibroblasts in the unaffected and affected skin areas of the same patient with lcSSc; second, because they demonstrate the histological/histochemical similarities between unaffected skin from patients with lcSSc and healthy control skin.


  • Inflammatory protein response in CDKL5-Rett syndrome: evidence of a subclinical smouldering inflammation

    by Alessio Cortelazzo, Claudio de Felice, Silvia Leoncini, Cinzia Signorini, Roberto Guerranti, Roberto Leoncini, Alessandro Armini, Luca Bini, Lucia Ciccoli, Joussef Hayek

    Background Mutations in the cyclin-dependent kinase-like 5 gene cause a clinical variant of Rett syndrome (CDKL5-RTT). A role for the acute-phase response (APR) is emerging in typical RTT caused by methyl-CpG-binding protein 2 gene mutations (MECP2-RTT). No information is, to date, available on the inflammatory protein response in CDKL5-RTT. We evaluated, for the first time, the APR protein response in CDKL5-RTT. Methods Protein patterns in albumin- and IgG-depleted plasma proteome from CDKL5-RTT patients were evaluated by two-dimensional gel electrophoresis/mass spectrometry. The resulting data were related to circulating cytokines and compared to healthy controls or MECP2-RTT patients. The effects of omega-3 polyunsaturated fatty acids (ω-3 PUFAs) were evaluated. Results CDKL5-RTT mutations resulted in a subclinical attenuated inflammation, specifically characterized by an overexpression of the complement component C3 and CD5 antigen-like, both strictly related to the inflammatory response. Cytokine dysregulation featuring a bulk increase of anti-inflammatory cytokines, predominantly IL-10, could explain the unchanged erythrocyte sedimentation rate and atypical features of inflammation in CDKL5-RTT. Omega-3 PUFAs were able to counterbalance the pro-inflammatory status. Conclusion For the first time, we revealed a subclinical smouldering inflammation pattern in CDKL5-RTT consisting in the coexistence of an atypical APR coupled with a dysregulated cytokine response.


  • Expression and oxidative modifications of plasma proteins in autism spectrum disorders: Interplay between inflammatory response and lipid peroxidation

    by Alessio Cortelazzo, Claudio De Felice, Roberto Guerranti, Cinzia Signorini, Silvia Leoncini, Gloria Zollo, Roberto Leoncini, Anna Maria Timperio, Lello Zolla, Lucia Ciccoli, et al.

    Purpose: A role for inflammation and oxidative stress is reported in autism spectrum disorders (ASDs). Here, we tested possible changes in expression and/or oxidative status for plasma proteins in subjects with ASDs.Experimental design: To evaluate protein expression and protein adducts of lipid peroxidation‐derived aldehyde, analysis of plasma proteins was performed in 30 subjects with ASDs and compared with 30 healthy controls with typical development, using a proteomic approach.Results: Significant changes were evidenced for a total of 12 proteins. Of these, ten were identified as proteins involved in the acute inflammatory response including alpha‐2‐macroglobulin, alpha‐1‐antitrypsin, haptoglobin, fibrinogen, serum transferrin, prealbumin, apolipoprotein A‐I apolipoprotein A‐IV, apolipoprotein J, and serum albumin. In addition, significant changes occurred for two immunoglobulins alpha and gamma chains.Conclusions and clinical relevance: Our present data indicate that an inflammatory response, coupled with increased lipid peroxidation, is present in subjects with ASDs. This information can provide new insight into the identification of potential plasma protein biomarkers in autism.


  • Erythrocyte Cytoskeletal-plasma Membrane Protein Network in Rett Syndrome: Effects of .-3 Polyunsaturated Fatty Acids

    by Alessio Cortelazzo, Claudio Felice, Roberto Guerranti, Roberto Leoncini, Alessandro Barducci, Silvia Leoncini, Cinzia Signorini, Gloria Zollo, Alessandra Pecorelli, Assunta Gagliardi, et al.

    Rett syndrome (RTT) is a rare and severe neurodevelopmental disorder, mainly caused (~90-95% of cases) by loss-of-function mutations in the X-linked methyl-CpG-binding protein 2 gene. Recent studies indicate an important role of oxidative stress in damaging the RTT erythrocytes. The present study aims at demonstrating that the abnormal erythrocyte morphology observed in RTT (i.e., leptocytosis) is related to protein expression changes and oxidative posttranslational modifications (PTMs). Furthermore, we evaluated whether protein changes could be rescued following ω-3 polyunsaturated fatty acids (ω-3 PUFAs) supplementation. Erythrocytes from RTT patients, either on or off ω-3 PUFAs, were examined for oxidative PTMs, protein expression, protein-protein interaction and biophysical parameters. Significant (P < 0.05) expression changes and oxidative PTMs for 12 proteins were evidenced in RTT, and related to increased susceptibility of erythrocytes to mechanical stress (i.e., spectrin alpha and beta chains, ankyrin, band 3, protein 4.1, adducin, protein 4.2, 55 kDa protein, beta-actin, tropomodulin, aldolase and glyceraldehyde-3-phosphate dehydrogenase). Half of these proteins were rescued after ω-3 PUFAs supplementation. Our findings indicate the occurrence of a significant disruption in the RTT erythrocyte cytoskeletal-membrane protein network as the result of redox imbalance and protein expression changes, which appear to be partially rescued by ω-3 PUFAs.


  • Erectile dysfunction and diabetes: Association with the impairment of lipid metabolism and oxidative stress

    by Arben Belba, Alessio Cortelazzo, Giansanti Andrea, Jacopo Durante, Laura Nigi, Francesco Dotta, Anna Maria Timperio, Lello Zolla, Roberto Leoncini, Roberto Guerranti, et al.


  • Gestione della glicemia nel Laboratorio di analisi cliniche: valutazione dell’efficacia tra vecchi e nuovi inibitori della glicolisi. Dati preliminari

    by Mariangela Longini, Elisa Belvisi, Roberto Leoncini, Roberto Guerranti, Carlo Scapellato

    . Il dosaggio della glicemia, effettuato nei Laboratori clinici, risulta associato a diverse problematiche. Per esempio la permanenza del campione in vitro, oltre alla leucocitosi e alla contaminazione batterica, favorisce la glicolisi con conseguente diminuzione della concentrazione di glucosio, stimata in circa il 7% per ogni ora che intercorre dal momento in cui è stato effettuato il prelievo ematico al dosaggio. A tale proposito risulta necessario migliorare la fase preanalitica in modo da uniformare e ottimizzare i dosaggi della glicemia. Degli accorgimenti risolutivi potrebbero essere la separazione precoce delle cellule o un raffreddamento veloce del campione, anche se risultano difficili da mettere in pratica. Il fluoruro noto come anticoagulante è anche un inibitore glicolitico, per cui il suo utilizzo, nel dosaggio glicemico, ha permesso una riduzione del problema, ma non la risoluzione, in quanto il fluoruro agisce solo a valle della glicolisi, precisamente sull’enzima enolasi. L’obiettivo è trovare sostanze inibenti la glicolisi che agiscano a monte di tale processo, annullando o riducendo il consumo di glucosio al minimo nella fase pre-analitica. Il citrato, comunemente utilizzato in Laboratorio come anticoagulante, ha la proprietà di agire nelle prime tappe della glicolisi inibendo l’esochinasi e la fosfofruttochinasi. . È stato valutato l’andamento della concentrazione di glucosio nel sangue nel tempo (nelle prime 6 ore dal prelievo ematico). Il dosaggio è stato eseguito su plasma, contenente fluoruro o citrato o una miscela di fluoruro e citrato, e su siero. La glicemia è stata dosata con il sistema Roche/Hitachi Cobas c501 (Roche, Monza, MI, Italia), che utilizza un sistema analitico enzimatico per la determinazione quantitativa del glucosio. . I risultati ottenuti riportano una significativa riduzione del valore glicemico per l’analisi effettuata in provette contenenti gel separatore, solo citrato, solo fluoruro; questa perdita risulta minima, invece, per i campioni conservati in provette contenenti la miscela di fluoruro e citrato. . Alla fine di questo studio è stato evidenziato come l’utilizzo di citrato combinato con floruro possa migliorare l’attendibilità del valore del dosaggio glicemico, utile soprattutto per i pazienti con valori glicemici borderline. . Dosing of blood glucose, carried out in a Laboratory, is grouped with a set of problems. For example, glycolysis is facilitated by leaving samples in test tubes, as well as by leukocytosis and bacterial contamination, resulting in reduced glucose concentration of about 7% every hour since the sample has been collected. Therefore, it is necessary to improve the preanalytical phase in order to standardize and optimize blood glucose dosages. Early separation of the cells or fast sample cooling can be good ways to resolve this, but they remain difficult to perform. Fluoride, known also as an anticoagulant, is also a glycolytic inhibitor, and its use in the assay of blood glucose has reduced, but not solved, the problem as fluoride inhibits only the enolase, a final enzyme in the glycolytic pathway. The objective is to find some substances that inhibit the glycolytic pathway upstream, annulling or reducing glucose consumption in the pre-analytic phase at its minimum. Citrate, which is commonly used in Laboratories as an anticoagulant, has the property of acting in the first stages of gliycolysis, inhibiting hexokinase and phosphofructokinase. . The glycaemia in the blood (in the first six hours after blood sampling) was measured over time. The measuring was performed on plasma, treated with fluoride or citrate or a mixture of both, and on serum. Blood glucose was measured out with a Roche/Hitachi Cobas c501 (Roche, Monza, MI, Italia) system, which uses an enzyme-based analytical system to determine quantitatively the amount of glucose. . Data obtained through the analysis of test tubes containing serum and plasma, only citrate or only fluoride, show a significant reduction of the glycemic value. This reduction is instead minimal in samples treated with the mixture of fluoride and citrate. . At the end of this study, it was shown how the use of citrate combined with fluoride may improve the glycemic dosage results reliability and this would prove to be useful especially for those patients with a borderline blood glucose value.